Chugai Pharmaceutical Total Non-Operating Income/Expense 2020-2025 | CHGCY

Chugai Pharmaceutical total non-operating income/expense for the twelve months ending March 31, 2025 was $0.005B, a 133% decline year-over-year.

  • Chugai Pharmaceutical annual total non-operating income/expense for 2024 was $0.007B, a 79.36% decline from 2023.
  • Chugai Pharmaceutical annual total non-operating income/expense for 2023 was $0.033B, a 299.95% decline from 2022.
  • Chugai Pharmaceutical annual total non-operating income/expense for 2022 was $-0.017B, a 27.81% decline from 2021.

Chugai Pharmaceutical Total Non-Operating Income/Expense 2020-2025 | CHGCY

  • Chugai Pharmaceutical annual total non-operating income/expense for 2024 was $0.007B, a 79.36% decline from 2023.
  • Chugai Pharmaceutical annual total non-operating income/expense for 2023 was $0.033B, a 299.95% decline from 2022.
  • Chugai Pharmaceutical annual total non-operating income/expense for 2022 was $-0.017B, a 27.81% decline from 2021.